The Texas tech firm Scimplify has raised $40 million in new funding to expand its online platform supporting how specialty chemicals are developed, manufactured, and distributed worldwide.
The backing comes as fluctuating tariffs and geopolitical tensions are forcing many industries to find innovative manufacturing solutions. That market upheaval is particular painful for specialty chemicals—which are ingredients found in everything from pharmaceuticals to agriculture—due to the sector’s fragmented and inflexible supply base, Scimplify says.
As a tool for coping with those disruptions, Scimplify says its platform is a full-stack solution, combining scientific expertise with a network of specialized plants to alleviate many supply chain issues. More specifically, the firm offers access to a network of over 200 specialized manufacturing plants across low-cost regions, creating an alternative to traditional manufacturing. Scimplify says it handles everything from R&D to specialized production, finding a manufacturing partner for each specific chemistry.,
With its new backing, the firm plans to boost its international growth, expanding both geographically and into new industry segments. The “series B” funding round was co-led by Accel and Bertelsmann with participation from UMI and existing investors including Omnivore and 3one4 Capital. This latest round brings Scimplify’s total funding to $54 million, following $13.5 million raised across seed and Series A rounds.
“Global supply chains are shifting like never before,” Sachin Santhosh, Co-Founder at Scimplify, said in a release. “For decades, specialty chemical manufacturers have invested millions in facilities that can only produce a handful of compounds, often running at partial capacity while lacking R&D capabilities. This creates a paradox: excess capacity alongside supply shortages. We’ve flipped this model, connecting our scientific teams with hundreds of manufacturing plants to create a responsive ecosystem that can adapt as market needs shift.”
